Cargando…

Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway

BACKGROUND: Acute respiratory distress syndrome (ARDS) is characterized by severe local and systemic inflammation. Ac2-26, an Annexin A1 Peptide, can reduce the lung injury induced by reperfusion via the inhibition of inflammation. The present study aims to evaluate the effect and mechanism of Ac2-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Yingnan, Qiu, Lin, Sun, Xikun, Liu, Hengyu, Gao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143635/
https://www.ncbi.nlm.nih.gov/pubmed/34008449
http://dx.doi.org/10.1080/07853890.2021.1925149
_version_ 1783696799018516480
author Ju, Yingnan
Qiu, Lin
Sun, Xikun
Liu, Hengyu
Gao, Wei
author_facet Ju, Yingnan
Qiu, Lin
Sun, Xikun
Liu, Hengyu
Gao, Wei
author_sort Ju, Yingnan
collection PubMed
description BACKGROUND: Acute respiratory distress syndrome (ARDS) is characterized by severe local and systemic inflammation. Ac2-26, an Annexin A1 Peptide, can reduce the lung injury induced by reperfusion via the inhibition of inflammation. The present study aims to evaluate the effect and mechanism of Ac2-26 in ARDS. METHODS: Thirty-two rats were anaesthetized and randomized into four groups: sham (S), ARDS (A), ARDS/Ac2-26 (AA), and ARDS/Ac2-26/BOC-2 (AAB) groups. Rats in the S group received saline for intratracheal instillation, while rats in the other three groups received endotoxin for intratracheal instillation, in order to prepare the ARDS and inject the saline, Ac2-26, and Ac2-26 combined with BOC-2. After 24 h, the PaO(2)/FiO(2) ratio was calculated. The lung tissue wet-to-dry weight ratio and the protein level in bronchoalveolar lavage fluid (BALF) were tested. Then, the cytokines in BALF and serum, and the inflammatory cells in BALF were investigated. Afterwards, the oxidative stress response and histological injury was evaluated. Subsequently, the epithelium was cultured and analyzed to estimate the effect of Ac2-26 on apoptosis. RESULTS: Compared to the S group, all indexes worsened in the A, AA, and AAB groups. Furthermore, compared to the S group, Ac2-26 significantly improved the lung injury and alveolar-capillary permeability, and inhibited the oxidative stress response. In addition, Ac2-26 reduced the local and systemic inflammation through the regulation of pro- and anti-inflammatory cytokines, and the decrease in inflammatory cells in BALF. Moreover, Ac2-26 inhibited the epithelium apoptosis induced by LPS through the modulation of apoptosis-regulated proteins. The protective effect of Ac2-26 on ARDS was partially reversed by the FPR inhibitor, BOC-2. CONCLUSION: Ac2-26 reduced the lung injury induced by LPS, promoted alveolar-capillary permeability, ameliorated the local and systemic inflammation, and inhibited the oxidative stress response and apoptosis. The protection of Ac2-26 on ARDS was mainly dependent on the FPR pathway.
format Online
Article
Text
id pubmed-8143635
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-81436352021-06-07 Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway Ju, Yingnan Qiu, Lin Sun, Xikun Liu, Hengyu Gao, Wei Ann Med Pulmonary Medicine BACKGROUND: Acute respiratory distress syndrome (ARDS) is characterized by severe local and systemic inflammation. Ac2-26, an Annexin A1 Peptide, can reduce the lung injury induced by reperfusion via the inhibition of inflammation. The present study aims to evaluate the effect and mechanism of Ac2-26 in ARDS. METHODS: Thirty-two rats were anaesthetized and randomized into four groups: sham (S), ARDS (A), ARDS/Ac2-26 (AA), and ARDS/Ac2-26/BOC-2 (AAB) groups. Rats in the S group received saline for intratracheal instillation, while rats in the other three groups received endotoxin for intratracheal instillation, in order to prepare the ARDS and inject the saline, Ac2-26, and Ac2-26 combined with BOC-2. After 24 h, the PaO(2)/FiO(2) ratio was calculated. The lung tissue wet-to-dry weight ratio and the protein level in bronchoalveolar lavage fluid (BALF) were tested. Then, the cytokines in BALF and serum, and the inflammatory cells in BALF were investigated. Afterwards, the oxidative stress response and histological injury was evaluated. Subsequently, the epithelium was cultured and analyzed to estimate the effect of Ac2-26 on apoptosis. RESULTS: Compared to the S group, all indexes worsened in the A, AA, and AAB groups. Furthermore, compared to the S group, Ac2-26 significantly improved the lung injury and alveolar-capillary permeability, and inhibited the oxidative stress response. In addition, Ac2-26 reduced the local and systemic inflammation through the regulation of pro- and anti-inflammatory cytokines, and the decrease in inflammatory cells in BALF. Moreover, Ac2-26 inhibited the epithelium apoptosis induced by LPS through the modulation of apoptosis-regulated proteins. The protective effect of Ac2-26 on ARDS was partially reversed by the FPR inhibitor, BOC-2. CONCLUSION: Ac2-26 reduced the lung injury induced by LPS, promoted alveolar-capillary permeability, ameliorated the local and systemic inflammation, and inhibited the oxidative stress response and apoptosis. The protection of Ac2-26 on ARDS was mainly dependent on the FPR pathway. Taylor & Francis 2021-05-19 /pmc/articles/PMC8143635/ /pubmed/34008449 http://dx.doi.org/10.1080/07853890.2021.1925149 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pulmonary Medicine
Ju, Yingnan
Qiu, Lin
Sun, Xikun
Liu, Hengyu
Gao, Wei
Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
title Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
title_full Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
title_fullStr Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
title_full_unstemmed Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
title_short Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
title_sort ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
topic Pulmonary Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143635/
https://www.ncbi.nlm.nih.gov/pubmed/34008449
http://dx.doi.org/10.1080/07853890.2021.1925149
work_keys_str_mv AT juyingnan ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway
AT qiulin ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway
AT sunxikun ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway
AT liuhengyu ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway
AT gaowei ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway